BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26930712)

  • 1. Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.
    Tibullo D; Barbagallo I; Giallongo C; Vanella L; Conticello C; Romano A; Saccone S; Godos J; Di Raimondo F; Li Volti G
    Oncotarget; 2016 May; 7(20):28868-80. PubMed ID: 26930712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of Hsp90 and heme oxygenase-1 induces apoptosis and endoplasmic reticulum stress in melanoma.
    Barbagallo I; Parenti R; Zappalà A; Vanella L; Tibullo D; Pepe F; Onni T; Li Volti G
    Acta Histochem; 2015 Oct; 117(8):705-11. PubMed ID: 26493719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells.
    Tibullo D; Giallongo C; Puglisi F; Tomassoni D; Camiolo G; Cristaldi M; Brundo MV; Anfuso CD; Lupo G; Stampone T; Li Volti G; Amenta F; Avola R; Bramanti V
    Mol Neurobiol; 2018 Apr; 55(4):3344-3350. PubMed ID: 28497200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
    Furfaro AL; Piras S; Passalacqua M; Domenicotti C; Parodi A; Fenoglio D; Pronzato MA; Marinari UM; Moretta L; Traverso N; Nitti M
    Biochim Biophys Acta; 2014 Apr; 1842(4):613-22. PubMed ID: 24380881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells.
    Fink EE; Mannava S; Bagati A; Bianchi-Smiraglia A; Nair JR; Moparthy K; Lipchick BC; Drokov M; Utley A; Ross J; Mendeleeva LP; Savchenko VG; Lee KP; Nikiforov MA
    Leukemia; 2016 Jan; 30(1):104-11. PubMed ID: 26205085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma.
    Ri M
    Int J Hematol; 2016 Sep; 104(3):273-80. PubMed ID: 27169614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.
    Zhang Z; Wang W; Ma D; Xiong J; Kuang X; Zhang S; Fang Q; Wang J
    Aging (Albany NY); 2020 Apr; 12(8):6611-6629. PubMed ID: 32298237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
    Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P
    Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib.
    Furfaro AL; Piras S; Domenicotti C; Fenoglio D; De Luigi A; Salmona M; Moretta L; Marinari UM; Pronzato MA; Traverso N; Nitti M
    PLoS One; 2016; 11(3):e0152465. PubMed ID: 27023064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib induces heme oxygenase-1 expression in multiple myeloma.
    Barrera LN; Rushworth SA; Bowles KM; MacEwan DJ
    Cell Cycle; 2012 Jun; 11(12):2248-52. PubMed ID: 22617388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma.
    Yao Y; Zhang Y; Shi M; Sun Y; Chen C; Niu M; Zhang Q; Zeng L; Yao R; Li H; Yang J; Li Z; Xu K
    J Leukoc Biol; 2018 Dec; 104(6):1105-1115. PubMed ID: 30024656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10.
    Xi H; Li L; Du J; An R; Fan R; Lu J; Wu YX; Wu SX; Hou J; Zhao LM
    Oncol Rep; 2017 Feb; 37(2):961-968. PubMed ID: 28000886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma.
    Yoshida T; Ri M; Kinoshita S; Narita T; Totani H; Ashour R; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
    PLoS One; 2018; 13(5):e0196780. PubMed ID: 29738534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.
    Wallington-Beddoe CT; Bennett MK; Vandyke K; Davies L; Zebol JR; Moretti PAB; Pitman MR; Hewett DR; Zannettino ACW; Pitson SM
    Oncotarget; 2017 Jul; 8(27):43602-43616. PubMed ID: 28467788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death.
    Yin L; Kufe T; Avigan D; Kufe D
    Blood; 2014 May; 123(19):2997-3006. PubMed ID: 24632713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression.
    Lee GH; Kim HK; Chae SW; Kim DS; Ha KC; Cuddy M; Kress C; Reed JC; Kim HR; Chae HJ
    J Biol Chem; 2007 Jul; 282(30):21618-28. PubMed ID: 17526500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance.
    Caillot M; Zylbersztejn F; Maitre E; Bourgeais J; Hérault O; Sola B
    Cells; 2020 Oct; 9(11):. PubMed ID: 33114738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
    Wada N; Kawano Y; Fujiwara S; Kikukawa Y; Okuno Y; Tasaki M; Ueda M; Ando Y; Yoshinaga K; Ri M; Iida S; Nakashima T; Shiotsu Y; Mitsuya H; Hata H
    Int J Oncol; 2015 Mar; 46(3):963-72. PubMed ID: 25530098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.